Jim Cramer: We Do Have Great COVID-19 Medicine, But Not the Scale

Author:
Publish date:
Video Duration:
4:55

President Donald Trump has been discharged from Walter Reed after being put on a regiment of dexamethasone, remdesivir and Regeneron's antibody cocktail.

"As long as Trump stays president he will fight any shutdown and go against any restraints on vaccines. Both of these could be pernicious given that there are hotspots that are undeniable and there are people who won't take the vaccines if they aren't fully tested," Jim Cramer wrote in his Real Money column on Tuesday. "Worse, he has said that we have drugs that can stop and reverse the viral load -- Regeneron's cocktail -- so what's the big deal. Of course the big deal is that the Regeneron drug is difficult to get. They can't make it fast enough and it hasn't been approved for general use."

Read more from Jim Cramer. 

And this comes on the heels of fears of a remdesivir shortage. 

Reports of shortages of the drug, the best-known virus inhibitor for patients with severe COVID-19, emerged on Tuesday, with hospitals in the Netherlands reporting they cannot currently order the drug from Gilead.

In the U.K., National Health Service hospitals were issued an alert last week that warned of an “increased demand against available supply,” telling doctors to be more selective about to whom they give the drug.

The NHS on Monday added to that warning, telling doctors to save the drug for those who “have the greatest capacity to benefit,” according to the Daily Mail newspaper. 

You can follow Jim Cramer and Katherine Ross on Twitter at @JimCramer and @byKatherineRoss. Read more from Katherine Ross here.

Latest Videos From TheStreet and Jim Cramer: